Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 1, 2001, Pages 57-64

  Gomez, R ^a   Huber, J ^a   Tombini, G ^a   Barros, H M T ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Antidepressants; Depression; Diabetes; Glucose tolerance; Glycemia

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; CLONAZEPAM; CYTOCHROME P450; DIAZEPAM; FLUOXETINE; GLUCOSE; HEMOGLOBIN A1C; IMIPRAMINE; INSULIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STREPTOZOCIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; MALE; NONHUMAN; RAT; RECEPTOR SENSITIVITY; STREPTOZOCIN DIABETES;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0035142886     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000100007     Document Type: Article

References (40)

1. Davis SN & Granner DK (1996). Insulina, fármacos hipoglicemiantes orais e a farmacologia do pâncreas endócrino. In: Hardman JG & Limbird LE (Editors), Goodman & Gilman: As Bases Farmacológicas da Terapêutica. 9th edn. Guanabara Koogan, Rio de Janeiro
2. Malerbi D & Franco LJ (1992). Brazilian Cooperative Group on the study of diabetes prevalence. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 years. Diabetes Care, 15: 509-516.
3. Spis K, Pietschmann P & Prager R (1995). A program to reduce onset distresses in unselected type I diabetic patients: effects on psychological variables and metabolic control. European Journal of Endocrinology, 132: 580-586.
4. Lillker SL (1980). Prevalence of diabetes in a manic-depressive population. Comparative Psychiatry, 21: 270-275.
5. Lustman PJ, Griffith LS, Gavard JA & Clouse RE (1992). Depression in adults with diabetes. Diabetes Care, 15: 1631-1639.
6. Gavard JA, Lustman PJ & Clouse RE (1993). Prevalence of depression in adults with diabetes. Diabetes Care, 16: 1167-1178.
7. Wredling RAM, Theorell PGT, Roll HM, Lins PES & Adamson UKC (1992). Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care, 15: 518-521.
8. Fifer SK, Mathias SD, Patrick DL, Mazonson PD, Lubeck DP & Buesching DP (1994). Untreated anxiety among adult primary care patients in a health maintenance organization. Archives of General Psychiatry, 51: 740-750.
9. Lustman PJ, Griffith LS & Clouse RE (1988). Depression in adults with diabetes: results of 5-year follow-up study. Diabetes Care, 11: 605-612.
10. Lustman PJ, Amado H & Wetzel RD (1983). Depression in diabetics: a critical appraisal. Comparative Psychiatry, 24: 65-74.
11. Lustman PJ, Griffith LS, Freedlard KE, Kissel SS & Clouse RE (1998). Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Annals of Internal Medicine, 129: 613-621.
12. Lowe LP, Tranel D, Wallace RB & Welty TK (1994). Type II diabetes and cognitive function. Diabetes Care, 17: 891-896.
13. Cameron OG, Kronfol Z, Greden JF & Caroll BJ (1984). Hypothalamic pituitary adreno-cortical activity in patients with diabetes mellitus. Archives of General Psychiatry, 41: 1090-1095.
14. Okamura F, Tashiro A, Utsumi A, Imai T, Suchi T & Hongo M (1999). Insulin resistance in patients with depression and its changes in the clinical course of depression: a report on three cases using the minimal model analysis. Internal Medicine, 38: 257-260.
15. Lustman PJ, Clouse RE & Freedland KE (1998). Management of major depression in adults with diabetes: implications of recent clinical trials. Seminars in Clinical Neuropsychiatry, 3: 102-114.
16. Sachs G, Spiess K & Moser G (1991). Glycosylated hemoglobin and diabetes self-monitoring (compliance) in depressed and non-depressed type I diabetes patients. Psychotherapie, Psychosomatik, Medizinische Psychologie, 41: 306-312.
17. Lustman PJ, Griffith LS, Freedland KE & Clouse RE (1997). The course of major depression in diabetes. General Hospital Psychiatry, 19: 138-143.
18. Goodnick PJ, Henry JH & Buki VM (1995). Treatment of depression in patients with diabetes mellitus. Journal of Clinical Psychiatry, 56: 128-136.
19. Erenmemisoglu A, Ozdogan UK, Saraymen T & Tutus A (1999). Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. Journal of Pharmacy and Pharmacology, 51: 741-743.
20. Ferigolo M, Barros HMT, Marquardt AR & Tannhauser M (1998). Comparison of behavioral effects of moclobemide and deprenyl during forced swimming. Pharmacology and Biochemical Behavior, 60: 431-437.
21. Gomez R & Barros HMT (2000). Ethopharmacology of the antideptessant effect of clonazepam in diabetic rats. Pharmacology and Biochemical Behavior, 66: 329-335.
22. Like AA & Rossini AA (1976). Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science, 193: 415-417.
23. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM & McGill JB (1997). Effects of nortriptyline on depression and glycemic control in diabetes: results of a double blind, placebo-controlled trial. Psychosomatic Medicine, 59: 241-250.
24. Kaplan SM, Mass JW, Pixley JM & Ross D (1960). Use of imipramine in diabetes. Effects on glycosuria and blood sugar levels. Journal of the American Medical Association. 174: 511-517.
25. Gupla B, Awasthi A & Jaju BP (1992). Effect of acute and chronic imipramine treatment on glucose homeostasis. Indian Journal of Medical Research, 96: 65-71.
26. Cooper AJ & Ashcroft G (1963). Potentiation of insulin hypoglycemia by MAOI antidepressant drugs. Lancet, 1: 407-409.
27. Potter WZ, Zaharko DS & Beck LV (1969). Possible role of hydrazine group in hypoglycemia associated with the use of certain monoamme-oxidase inhibitors (MAOIs). Diabetes, 18: 538-541.
28. Bressler R & Johnson D (1992). New pharmacological approaches to therapy of NIDDM. Diabetes Care, 15: 792-805.
29. Takhar J & Williamson P (1999). Hypoglycemia associated with high doses of sertraline end sulfonylurea compound in a non-insulin-dependent diabetes mellitus patient. Canadian Journal of Pharmacology, 6: 12-14.
30. Cohn JB & Wilcox C (1985). A comparison of fluoxetine, imipramine, and placebo in patients with maior depressive disorder. Journal of Clinical Psychiatry, 46: 26-31.
31. Maheux P, Ducros F, Bourque J, Garon J & Chiasson JL (1997). Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss. International Journal of Obesity and Related Metabolic Disorders, 21: 97-102.
32. Potter Van Lonn BJ, Radder JK, Frolich M, Krans HM, Zwinderman AH & Meinders AE (1992). Fluoxetine increases insulin action in obese non-diabetic and obese non-insulin-dependent diabetic individuals. International Journal of Obesity and Related Metabolic Disorders, 16: 79-85.
33. True BL, Perry PJ & Burns EA (1987). Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy. American Journal of Psychiatry, 144: 1220-1221.
34. Daubresse JC, Kolanowski J, Krzentowski G, Kutnowski M, Scheen A & Van Gaal L (1996). Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study. Obesity Research, 4: 391-396.
35. O'Kade M, Wiles PG & Wales JK (1994). Fluoxetine in the treatment of obese type 2 diabetic patients. Diabetes Medicine, 11: 105-110.
36. Goodnick PJ, Kumar A, Henry JH, Buki VM & Goldberg RB (1997). Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacology Bulletin, 33: 261-264.
37. Richelson I (1996). Synaptic effects of antidepressants. Journal of Clinical Psychopharmacology, 16 (Suppl 2): 1-9.
38. Petty F (1997). GABA and mood disorders: a brief review and hypothesis. Journal of Affective Disorders, 34: 275-281.
39. Jonas JM & Cohon MS (1993). A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic and depression: a review of the literature. Journal of Clinical Psychiatry, 54: 25-45.
40. Gomez R, Asnis N, Tannhauser SL & Barros HMT (1999). GABA agonists differentially modify blood glucose levels of diabetic rats. Japanese Journal of Pharmacology, 80: 327-331.